BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03010176-completion@plaintrial.com
DTSTAMP:20261029T044828Z
DTSTART;VALUE=DATE:20220421
SUMMARY:Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrol
 izumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or 
 Lymphomas (MK-1454-001) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03010176
URL:https://plaintrial.com/trial/NCT03010176
END:VEVENT
END:VCALENDAR